Find the latest pharmaceutical market place for formulations enquiry about Upadacitinib on PharmaCompass.com.

Tender// Various Finished Dosage Formulations needed in Estonia [ENA09367]

Sihtasutus Tartu Ülikooli Kliinikum is looking for supplies of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 25-Jan-2021.
1. Pertuzumab (420 mg) Concentration for Infusion. The required quantity is 450 units.
2. Pembrolizumab (100 mg) Powder for solution for Injection. The required quantity is 2,000 units.
3. Nivolumab (240 mg/ 24 ml) Concentration for Infusion. The required quantity is 480 units.
4. Obinutuzumb (1000 mg) Concentration for Infusion. The required quantity is 100 units.
5. Siponimodum (2 mg) Tablets. The required quantity is 1,000 units.
6. Upadacitinib (15 mg) Tablets. The required quantity is 2,000 units.

Reply

29 Dec 2020

Various Finished Dosage Formulations needed in Jordan [ENA08350]

Swe Moc Group AB, a distributor company that deals in various pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations. The suppliers must support this enquiry with CEP or FDA. The final market is the Middle East countries. Interested suppliers can contact them via their email: mohamed.abdo@swemoc.com.
1. Ribomustin (100 mg/ 60 ml) Vial. The required quantity is 60 units.
2. Cabozantinib (60 mg) Tablets. The required quantity is 30 tablets in 68 units.
3. Ponatinib (15 mg) Tablets. The required quantity is 30 tablets in 80 units.
4. Upadacitinib (15 mg) Tablets. The required quantity is 28 tablets in 70 units.
5. Erwinase (10,000 units/ vial). The required quantity is 120 units.

Reply

25 Aug 2020

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.